'Investing in Medical Nanotechnologies', Royal Garden Hotel, London, 13-14th December 2006
Organised by the Institute of Nanotechnology, the first annual 'Investing in Medical Nanotechnologies' conference and exhibition will showcase the state-of-the-art technologies in nanomedicine.
Attended by major industrial players, start ups, investors, business analysts and consultants, this event promises to spotlight cutting-edge technologies and routes to finance.
Keynote Speakers:
- Prof. Sir Michael Rawlins, Chairman, National Institute of Clinical Excellence, UK
- Dr . Paul Smit, Senior Vice President, Philips Medical Systems, Netherlands
- Dr. Leonard Fass, Director, GE Healthcare, UK
- Dr Philippe Cleuziat, Director, bioMérieux, France
- Mr. Kim Kreilgaard, Head of Division, European Investment Bank, Luxembourg
- Dr Thomas. K. Epprecht, Senior Risk Specialist, Swiss Reinsurance Company, Switzerland
- Dr. Ogan Gurel, Chairman, Aesis Research Group,USA
- Dr. Arne Hengerer, Director, Molecular MRI, Siemens Medical Solutions, Germany
Participating Companies Include:
Glaxo Smithkline, Johnson & Johnson, Smith&Nephew, European Medicines Agency (EMEA), Mayatech Corporation, NorthStar Equity Investors, Orla Protein Technologie s, Nanotope, Oxonica Healthcare, Oxford NanoLabs, Qinetiq Nanomaterials, Akubio, Surface Innovation, Innospan, Photonix, London Centre for Nanotechnology, Eminate, Kelvin Nanotechnologies, Nanoviricides, SPI Lasers UK ...and many more!
View the conference programme at http://www.nanomednet.org/conference/programme.htm
View the speakers' abstracts at http://www.nanomednet.org/conference/abstracts.htm
Only 1 month remaining - register online now at https://www.nano.org.uk/payments
A limited number of opportunities still exist for exhibitors.
Contact: Tiju Joseph
Tel: 44 (0)141 330 8734
Email: tiju.joseph@nano.org.uk
